Citicoline: pharmacological and clinical review, 2022 update
1Departamento Médico. Ferrer, 08028 Barcelona, España.
Abstract:
This review is based on the previous one published in 2016 (Secades JJ. Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol 2016; 63 (Supl 3): S1-S73), incorporating 176 new references, having all the information available in the same document to facilitate the access to the information in one document. This review is focused on the main indications of the drug, as acute stroke and its sequelae, including the cognitive impairment, and traumatic brain injury and its sequelae. There are retrieved the most important experimental and clinical data in both indications.
More Related Videos
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Clinical Trials: Overview
Direct-Acting Cholinergic Agonists: Pharmacokinetics
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Direct-Acting Cholinergic Agonists: Therapeutic Uses


